Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous flow peritoneal dialysis: solution formulation and biocompatibility.

J Passlick-Deetjen1, C Lage, A Jörres

  • 1Fresenius Medical Care, Bad Homburg, Germany. jutta.Passlick-Deetjen@fmc-ag.de

Seminars in Dialysis
|October 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform.

The journal of prevention of Alzheimer's disease·2024
Same author

Screening macroalgae for mitigation of enteric methane in vitro.

Scientific reports·2023
Same author

Fatal consequences of decreased sensitivity to pain and temperature in a frontotemporal dementia patient.

Neurocase·2020
Same author

[S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare : Long version].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

[S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2020
Same author

[Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2018
Same journal

Intracardiac Vascular Access for Hemodialysis Despite Associated Ascending Aortic Aneurysm.

Seminars in dialysis·2026
Same journal

Measures of Equivalent Hemodialysis Urea Clearance and Their Proposed Utility for Monitoring Adequacy.

Seminars in dialysis·2026
Same journal

Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

Seminars in dialysis·2026
Same journal

Severe Hematoma Following Initial Arteriovenous Fistula Puncture in a Hemodialysis Patient, Emphasizing Thoracic Outlet Syndrome: A Case Report.

Seminars in dialysis·2026
Same journal

Phosphate Kinetic Modeling in Patients Treated With Hemodialysis or Hemodiafiltration: A Prospective, Multicenter, Cross-Sectional Study.

Seminars in dialysis·2026
Same journal

Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients.

Seminars in dialysis·2026
See all related articles

New peritoneal dialysis fluids (PDFs) with bicarbonate buffering and fewer glucose degradation products (GDPs) improve patient comfort and preserve kidney function. Continuous flow peritoneal dialysis (CFPD) offers further optimization for end-stage chronic disease treatment.

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Medical Technology

Background:

  • Peritoneal dialysis (PD) is a key therapy for end-stage chronic disease, but conventional fluids can harm the peritoneal membrane.
  • Conventional PDFs have acidic pH, high lactate, glucose, and glucose degradation products (GDPs), compromising membrane integrity.
  • Optimizing PD fluids (PDFs) is crucial for long-term PD therapy success and patient outcomes.

Purpose of the Study:

  • To evaluate novel bicarbonate-buffered PDFs and continuous flow PD (CFPD) for improved peritoneal membrane preservation.
  • To compare the biocompatibility and clinical efficacy of novel PDFs versus conventional solutions.
  • To explore CFPD's potential for personalized acid-base correction and enhanced cell function.

Main Methods:

Related Experiment Videos

  • In vitro assessment of novel bicarbonate-buffered PDFs compared to conventional lactate-buffered PDFs.
  • Clinical evaluation of novel PDFs, focusing on patient comfort, membrane transport, and effluent markers.
  • Conceptual analysis of continuous flow peritoneal dialysis (CFPD) for optimized fluid delivery and composition.

    • Main Results:

    • Novel bicarbonate-buffered PDFs show improved in vitro biocompatibility and reduced GDPs compared to conventional PDFs.
    • Clinically, novel PDFs decrease inflow pain and enhance peritoneal membrane transport, ultrafiltration, and integrity markers.
    • CFPD offers individualized acid-base correction and may restore peritoneal cell functions through optimized fluid parameters.

    Conclusions:

    • Bicarbonate-buffered PDFs represent a significant advancement in preserving peritoneal membrane function.
    • Novel PDFs improve clinical outcomes and patient experience in peritoneal dialysis.
    • CFPD presents a promising future direction for optimizing peritoneal dialysis therapy and membrane longevity.